[Form 4] American Healthcare REIT, Inc. Insider Trading Activity

Rhea-AI Filing Summary

American Healthcare REIT (NYSE:AHR) filed a Form 4 disclosing that Non-Executive Chairman and Director Jeffrey T. Hanson received 3,042 restricted common shares on 25 Jun 2025 following his re-election to the board. The grant was made at $0 cost and will vest in full on 25 Jun 2026.

Post-transaction, Hanson holds 41,808 shares directly and 85,163 shares indirectly through family trusts, retirement accounts and pension plans, bringing his total reported beneficial ownership to roughly 126,971 AHR shares. The filing also notes that securities held by NCT-107, LLC—a charitable foundation in which Hanson lacks pecuniary interest—will no longer be included in his Section 16 reports.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hanson Jeffrey T

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., SUITE 300

(Street)

IRVINE CA 92612

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Non-Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/25/2025		A		3,042(1)	A	$0	41,808	D
Common Stock								54,778	I	By Hanson Family Trust dated 06/14/2005(2)
Common Stock								5,552	I	By April L. Hanson IRA(3)
Common Stock								2,515	I	By Crescentridge 401K Plan(4)
Common Stock								16,720	I	By Defined Benefit Pension Plan(5)
Common Stock								729	I	By Spouse's Crescentridge 401K Plan(6)
Common Stock								4,869	I	By JTH Holdings LLC DBPP(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Upon his re-election as a director to the board of directors of the Issuer on June 25, 2025, the Reporting Person was granted 3,042 shares of restricted common stock on June 25, 2025. The reported shares of restricted common stock vest on June 25, 2026.

2. The reported shares are held directly by Jeffrey T Hanson and April L Hanson Family Trust dated 06/14/2005, and indirectly by Mr. Hanson and April L Hanson, Trustees. April L. Hanson is the wife of the reporting person.

3. The reported shares are owned by April L. Hanson through her investment retirement account.

4. The reported shares are owned by Mr. Hanson through his Crescentridge Inc. 401(k) plan.

5. The reported shares are held directly in a defined benefit pension plan, of which Mr. Hanson serves as Trustee.

6. The reported shares are owned by April L. Hanson through her Crescentridge Inc. 401(k) plan.

Remarks:

Mr. Hanson previously included in his Section 16 reports securities held directly by NCT-107, LLC, a charitable foundation. However, Mr. Hanson has no direct or indirect pecuniary interest (as such term is defined in Rule 16a-1(a)(2) under the Securities Exchange Act of 1934, as amended) in the securities held directly by NCT-107, LLC and, accordingly, has no obligation to report such securities in his Section 16 reports. As such, effective with this Form 4, Mr. Hanson is no longer reporting any of the securities held directly by NCT-107, LLC in his Section 16 reports.

	/s/ JEFFREY T. HANSON	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AHR shares did Jeffrey T. Hanson acquire on June 25, 2025?

The Form 4 reports a grant of 3,042 restricted common shares to Jeffrey T. Hanson.

When will the newly granted restricted shares to Jeffrey T. Hanson vest?

The restricted shares fully vest on June 25, 2026.

What is Jeffrey T. Hanson's total beneficial ownership of AHR after this transaction?

Following the grant, Hanson reports ownership of approximately 126,971 AHR shares (41,808 direct and 85,163 indirect).

Why are NCT-107, LLC shares no longer included in Hanson's Section 16 reports?

The filing states Hanson has no direct or indirect pecuniary interest in NCT-107, LLC’s holdings, removing his obligation to report them.